| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439277 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
Immune contexture of SCLC may differ according to stage. The presence of FOXP3-positive TILs is a potential prognostic marker for stage I-III SCLCs and warrants further investigation.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
L. Bonanno, A. Pavan, M.V. Dieci, E. Di Liso, M. Schiavon, G. Comacchio, I. Attili, G. Pasello, F. Calabrese, F. Rea, A. Favaretto, M. Rugge, V. Guarneri, M. Fassan, P.F. Conte,